WebCynapseDx (formerly CellCap Technologies) is a company that develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from neurodegenerative diseases. View company Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via … WebCynapseDx has been developing products to isolate proteins or cells from whole blood since 2012. At the heart of our techniques is a concentration step, which enriches the …
Novel Aggregated Biomarker Assay Technology
WebJun 8, 2024 · CynapseDx develops products to isolate proteins or cells from whole blood. Its primary focus is neurodegenerative diseases, such as Parkinson’s or Alzheimer’s Disease. WebCynapseDx's key executives include Damian Bond and 2 others. Damian Bond Chief Executive Peter Foster Chairman Christopher Stanley Chief Technology Officer Source: cynapsedx.com Report incorrect company information Key Executive Tracking Receive notifications of key executive changes Get started Executives of similar companies Vivid … great falls montana hockey tournament
CynapseDx Company Profile: Acquisition & Investors PitchBook
http://cynapsedx.com/contact-us WebJul 12, 2012 · CynapseDx's latest funding round was a Seed VC for $0.11M on July 12, 2012. View all funding This profile has not been claimed. You're more than your latest … WebExplore {CynapseDx's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. CynapseDx CEO, Founder, Key Executive Team, Board of Directors & Employees great falls montana jury duty